Add like
Add dislike
Add to saved papers

Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases.

In this study, we tested the anti-metastatic activity of Ipomoea obscura extract and elucidated its underlying mechanisms by in vitro system using B16F-10 melanoma cells and in vivo experimental lung metastasis model. I. obscura suppressed proliferation, invasion and migration of highly metastatic B16F-10 melanoma cells in vitro. I. obscura could also decrease transcription factors such as nuclear factor kappaB (NF-kappaB) and activator protein (AP-1) in B16F-10 melanoma cells. Administration of I. obscura resulted significant suppression of B16F-10 melanoma induced tumor nodule formation and enhanced the survival of tumor-bearing mice. The level of various biochemical parameters associated with lung metastasis were also found to be decreased by the I. obscura treatment. A significant down regulation in the expression of inflammatory mediators such inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), pro-inflammatory cytokines related to tumor metastasis was observed by the treatment with I. obscura. Higher expression levels of pro-metastatic genes such as matrix metalloproteinase (MMP-2 and 9), was observed in the metastatic group, but these were down-regulated by the treatment with I. obscura. The endogenous MMP inhibitor tissue inhibitor of metalloproteinases (TIMP) was found to be up-regulated by I. obscura treatment. Our results indicate that the anti- invasive and antimetastatic effect of I. obscura is mediated at least in part by reduced expression of inflammatory mediators by inhibiting NF-kappaB signaling with their downstream targets iNOS, COX-2 and pro-inflammatory cytokine and also by inhibiting MMP-9 and MMP-2.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app